CHOLOXIN Drug Patent Profile
✉ Email this page to a colleague
When do Choloxin patents expire, and when can generic versions of Choloxin launch?
Choloxin is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in CHOLOXIN is dextrothyroxine sodium. Additional details are available on the dextrothyroxine sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHOLOXIN?
- What are the global sales for CHOLOXIN?
- What is Average Wholesale Price for CHOLOXIN?
Summary for CHOLOXIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 100 |
| Patent Applications: | 1,764 |
| DailyMed Link: | CHOLOXIN at DailyMed |
US Patents and Regulatory Information for CHOLOXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | CHOLOXIN | dextrothyroxine sodium | TABLET;ORAL | 012302-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | CHOLOXIN | dextrothyroxine sodium | TABLET;ORAL | 012302-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | CHOLOXIN | dextrothyroxine sodium | TABLET;ORAL | 012302-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | CHOLOXIN | dextrothyroxine sodium | TABLET;ORAL | 012302-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
